All material subject to strictly enforced copyright laws. © 2021 Euromoney Institutional Investor PLC group
Equity

Oxford Nanopore seeks valuation of up to £3.8bn

Smartphone with website of company Oxford Nanopore Technologies Limited on screen in front of business logo. Focus on top-left of phone display.

The UK biotech company has chosen to list on its home market rather than go to the Nasdaq in New York, the traditional listing venue for companies in the industry

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree